DICOM PS3.16 2020a - Content Mapping Resource |
Page 451 |
TID 10021 |
|
TID 10022 |
|
TID 1002 |
|
Radiopharmaceutical |
|
|
Radiopharmaceutical |
|
|
Observer Context |
|
Radiation Dose |
|
Administration Event |
|
|
|
|
|
|
TID 10024 |
|
TID 10023 |
|
|
|
|
Imaging Agent |
|
Organ Dose |
|
|
|
|
Administration |
|
|
|
|
|
|
|
|
|
|
|
Patient Characteristics |
|
|
|
|
|
|
|
|
|
TID 1020 |
|
|
|
|
|
|
|
Person Participant |
|
|
|
|
|
|
|
|
Figure A-17. Radiopharmaceutical Radiation Dose SR IOD Template Structure
TID 10021 Radiopharmaceutical Radiation Dose
This Template defines a container (the root) with subsidiary Content Items, each of which corresponds to a single Radiopharmaceut- ical Administration Dose event entry. There is a defined recording observer (the system and/or person responsible for recording the assay of the radiopharmaceutical, and the person administered the radiopharmaceutical). Multiple Radiopharmaceutical Radiation Dose objects may be created for one study. Radiopharmaceutical Start DateTime in TID 10022 “Radiopharmaceutical Administration Event Data” will convey the order of administrations.
Type: |
Extensible |
Order: |
Significant |
Root: |
Yes |
Table TID 10021. Radiopharmaceutical Radiation Dose
|
NL |
Rel with Parent |
VT |
Concept Name |
VM |
Req Condition Value Set |
|
|
|
|
|
|
|
Type |
Constraint |
1 |
|
|
CONTAINEREV (113500, DCM, |
1 |
M |
Root node |
|
|
|
|
|
"Radiopharmaceutical Radiation |
|
|
|
|
|
|
|
|
Dose Report") |
|
|
|
1b |
> |
HAS CONCEPT INCLUDE |
DTID 1204 “Language of Content |
1 |
U |
|
|
|
MOD |
|
|
Item and Descendants” |
|
|
|
2 |
> |
HAS CONCEPT CODE |
EV(363589002,SCT,"Associated |
1 |
M |
DCID 3108 |
|
|
MOD |
|
|
Procedure") |
|
|
“NM/PET |
|
|
|
|
|
|
|
|
Procedures” |
3 |
>> |
HAS CONCEPT CODE |
EV (363703001, SCT, "Has |
1 |
M |
DCID 3629 |
|
|
MOD |
|
|
Intent") |
|
|
“Procedure |
|
|
|
|
|
|
|
|
Intent” |
4 |
> |
CONTAINS |
INCLUDE |
DTID10022“Radiopharmaceutical |
1 |
M |
|
|
|
|
|
|
Administration Event Data” |
|
|
|
5 |
> |
CONTAINS |
INCLUDE |
DTID 10024 “Imaging Agent |
1 |
U |
|
|
|
|
|
|
Administration Patient |
|
|
|
|
|
|
|
|
Characteristics” |
|
|
|
6 |
> |
CONTAINS |
TEXT |
EV (121106, DCM, "Comment") |
1 |
U |
|
Content Item Descriptions
Row 2 |
The associated procedure is the procedure performed, or if no procedure was performed the procedure |
|
that was ordered. |
TID 10022 Radiopharmaceutical Administration Event Data
The Radiopharmaceutical Administration Event conveys the dose and assay and time information of a single radiopharmaceutical event. A Radiopharmaceutical Administration event is one radioactive pharmaceutical administered to a patient.
Type: |
Extensible |
Order: |
Significant |
|
|
|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 453 |
|
NL |
Rel with |
VT |
Concept Name |
VM |
Req Condition |
Value Set Constraint |
|
|
Parent |
|
|
|
Type |
|
16 |
> |
CONTAINS |
NUM |
EV (113509, DCM, |
1 |
U |
UNITS = EV (MBq, |
|
|
|
|
"Post-Administration |
|
|
UCUM, "MBq") |
|
|
|
|
Measured Activity") |
|
|
|
17 |
>> |
HAS OBS |
CODE |
EV (113540, DCM, "Activity |
1 |
U |
DCID 10041 “Source of |
|
|
CONTEXT |
|
Measurement Device") |
|
|
Radioisotope Activity |
|
|
|
|
|
|
|
Information” |
18 |
>> |
HAS OBS |
INCLUDE |
DTID 1002 “Observer |
1-n |
U |
|
|
|
CONTEXT |
|
Context” |
|
|
|
19 |
> |
CONTAINS |
INCLUDE |
DTID 10023 “Organ Dose” |
1-n |
U |
|
20 |
> |
CONTAINS |
CODE |
EV(410675002,SCT,"Route 1 |
M |
BCID 11 “Route of |
|
|
|
|
of administration") |
|
|
Administration” |
21 |
>> |
HAS |
CODE |
EV (272737002, SCT, "Site |
1 |
MCIF Row 20 |
DCID 3746 |
|
|
PROPERTIES |
of") |
|
equals |
“Percutaneous Entry |
|
|
|
|
|
|
(47625008, |
Site” |
|
|
|
|
|
|
SCT, |
|
|
|
|
|
|
|
"Intravenous |
|
|
|
|
|
|
|
route") or |
|
|
|
|
|
|
|
(78421000, |
|
|
|
|
|
|
|
SCT, |
|
|
|
|
|
|
|
"Intramuscular |
|
|
|
|
|
|
route") |
|
22 |
>>> HAS |
CODE |
EV (272741003, SCT, |
1 |
MCIF Row 21 hasDCID 244 “Laterality” |
|
|
CONCEPT |
|
"Laterality") |
|
laterality |
|
|
|
MOD |
|
|
|
|
|
23 |
> |
CONTAINS |
INCLUDE |
DTID 1020 “Person |
1-n |
M |
$PersonProcedureRole |
|
|
|
|
Participant” |
|
|
= EV (113851, DCM, |
|
|
|
|
|
|
|
"Irradiation |
|
|
|
|
|
|
|
Administering") |
24 |
> |
CONTAINS |
CODE |
EV (121147, DCM, "Billing |
1-n |
U |
|
|
|
|
|
Code(s) ") |
|
|
|
25 |
> |
CONTAINS |
CODE |
EV (113510, DCM, "Drug |
1-n |
U |
|
|
|
|
|
Product Identifier") |
|
|
|
26 |
> |
CONTAINS |
TEXT |
EV (111529, DCM, "Brand |
1 |
U |
|
|
|
|
|
Name") |
|
|
|
27 |
> |
CONTAINS |
TEXT |
EV (113511, DCM, |
1 |
U |
|
|
|
|
|
"Radiopharmaceutical |
|
|
|
|
|
|
|
Dispense Unit Identifier") |
|
|
|
28 |
>> |
CONTAINS |
TEXT |
EV (113512, DCM, |
1-n |
U |
|
|
|
|
|
"Radiopharmaceutical Lot |
|
|
|
|
|
|
|
Identifier") |
|
|
|
29 |
>> |
CONTAINS |
TEXT |
EV(113513,DCM,"Reagent1-n |
U |
|
|
|
|
|
Vial Identifier") |
|
|
|
30 |
>> |
CONTAINS |
TEXT |
EV (113514, DCM, |
1-n |
U |
|
|
|
|
|
"Radionuclide Identifier") |
|
|
|
31 |
> |
CONTAINS |
TEXT |
EV (113516, DCM, |
1 |
U |
|
|
|
|
|
"Prescription Identifier") |
|
|
|
32 |
> |
CONTAINS |
TEXT |
EV (121106, DCM, |
1 |
U |
|
|
|
|
|
"Comment") |
|
|
|
Content Item Descriptions
|
|
|
|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 455 |
|
NL |
Rel with Parent |
VT |
Concept Name |
VM |
Req |
ConditionValue Set Constraint |
|
|
|
|
|
|
|
Type |
|
6 |
> |
CONTAINS |
NUM |
EV (113518, DCM, "Organ |
1 |
M |
UNITS = EV (mGy, |
|
|
|
|
|
Dose") |
|
|
UCUM, "mGy") |
7 |
>> |
HAS |
CODE |
EV (121406, DCM, |
1 |
MC XORRow8BCID 10040 |
|
|
PROPERTIES |
|
|
"Reference Authority") |
|
|
“Radiopharmaceutical |
|
|
|
|
|
|
|
|
OrganDoseReference |
|
|
|
|
|
|
|
|
Authority” |
8 |
>> |
HAS |
TEXT |
EV (121406, DCM, |
1 |
MC XORRow7 |
|
|
PROPERTIES |
|
|
"Reference Authority") |
|
|
|
Content Item Descriptions |
|
|
|
|
|
|
Row 3 |
For paired organs, use (51440002, SCT, "Bilateral") to report the estimated absorbed dose for both |
|
|
organs. |
|
|
|
|
|
Row 4 |
The estimated mass of organ in grams used when calculating the organ dose. |
Row 5 |
Method used to obtain the estimate. This could include a method that does not involve performing a |
|
|
measurement (e.g., Standard Organ Mass Tables). |
|
|
Row 6 |
Organ dose (in units of mGy). Organ is specified by row 2. |
|
TID 10024 Imaging Agent Administration Patient Characteristics
This Template describes the characteristics of the patient that are specific to the current clinical presentation (visit). In the case of radiopharmaceuticals, the characteristics noted may affect the activity received, and how dose is calculated for the patient. Patient Characteristic concepts in this Template, which may replicate attributes in the Patient Study Module, are included here as possible targets of by-reference relationships from other Content Items in the SR tree.
Type: |
Extensible |
Order: |
Significant |
Root: |
No |
Table TID 10024. Imaging Agent Administration Patient Characteristics
|
NL Rel with Parent VT |
Concept Name |
VM |
ReqCondition Value Set Constraint |
|
|
|
|
|
|
Type |
|
1 |
|
|
CONTAINEREV (121118, DCM, "Patient |
|
|
|
|
|
|
|
Characteristics") |
|
|
|
2 |
> |
CONTAINS |
CODE |
EV (109054, DCM, "Patient 1-n |
U |
DCID 10045 |
|
|
|
|
state") |
|
|
“Radiopharmaceutical |
|
|
|
|
|
|
|
Patient State” |
|
|
|
|
|
|
|
DCID 64 “Imaging Agent |
|
|
|
|
|
|
|
Administration Patient |
|
|
|
|
|
|
|
State” |
3 |
> |
CONTAINS |
NUM |
EV (121033, DCM, "Subject 1 |
U |
UNITS = DCID 7456 “Units |
|
|
|
|
Age") |
|
|
of Measure for Age” |
4 |
> |
CONTAINS |
CODE |
EV (121032, DCM, "Subject 1 |
U |
DCID 7455 “Sex” |
|
|
|
|
Sex") |
|
|
|
5 |
> |
CONTAINS |
NUM |
EV (8302-2, LN, "Patient |
1 |
U |
UNITS = EV (cm, UCUM, |
|
|
|
|
Height") |
|
|
"cm") |
6 |
> |
CONTAINS |
NUM |
EV (29463-7, LN, "Patient |
1 |
U |
UNITS = EV (kg, UCUM, |
|
|
|
|
Weight") |
|
|
"kg"). |
7 |
> |
CONTAINS |
NUM |
EV (8277-6, LN, "Body |
1 |
U |
UNITS = EV (m2, UCUM, |
|
|
|
|
Surface Area") |
|
|
"m^2") |